“ONE OF THE BIGGEST INNOVATIONS IN HAIR LOSS WE’VE SEEN IN TWENTY-FIVE YEARS” -- BOSLEYMD® TEAMS WITH START-UP YUVA BIOSCIENCES IN NATIONAL LAUNCH OF BREAKTHROUGH TECHNOLOGY
https://t.co/sx0J9S5Q3O
Excited about the first launch of a product using YuvaBio technology! BosleyMD just launched Revive+, co-created by Bosley Doctors and Yuva Biosciences, available now at CVS nationwide, as well as online through https://t.co/ISndzBxcZF, https://t.co/3pXcwpVCT5, and more!
The Pride India Awards presented the Indian Icon Award for Company of the Year to Dr. Keshav Singh and Yuva Biosciences at the February 25, 2023 ceremony at Shangri La Hotel
A4LI is proud to announce the founding of the Congressional Caucus for Longevity Science. The formation of the “Longevity Science Caucus” is a transformational moment for the longevity biotechnology industry and the movement to increase healthy human lifespans.
Mark your calendar for Octane’s Annual Aesthetics Tech Forum in Newport Beach, CA on January 26-27th! YuvaBio's Greg Schmergel will be presenting. Join the world’s top aesthetics executives, leading physicians, and entrepreneurs for two days of discussions.
Ever wondered why you develop dry skin as you grow old? Dr. Singh's newest study provides the first causal link between mitochondrial dysfunction and sebaceous gland pathology. https://t.co/CXnGYXODZW
You can hear our scientific founder Dr. Keshav Singh on the Finding Genius podcast speaking about "Exploring the Intricacies of Mitochondrial Research": https://t.co/xtOLLAPBNX
Our Scientific Founder Dr. Keshav Singh is speaking at the Reproductive Aging Conference on June 9th on the topic of "Mitochondria as regulator of ovarian aging"
Almost 20% of people believe they will live to see their 100th birthday🎂. However, #healthspan must be improved with longer #lifespan.
Read more in https://t.co/FPXOGziaLB’s Annual Report 2021 for free HERE:
https://t.co/vqbExTz2WI
Worth noting genetic manipulations that robustly increase longevity in mice are not naturally occurring. They would be strongly selected against. Absence of such variants from the gene pool is *expected* in humans. That does not mean such variants would not increase longevity.
Our scientific founder Dr. Keshav Singh will be speaking an exciting upcoming event on mitochondria-targeted drug development, Feb 22-24: https://t.co/C3IHtmNLWa